Dr. David Hansen, MD

NPI: 1003105768
Total Payments
$26,944
2022 Payments
$25,871
Companies
4
Transactions
7

Payment Breakdown by Category

Research$25,844 (95.9%)
Other$630.00 (2.3%)
Travel$400.00 (1.5%)
Education$43.74 (0.2%)
Food & Beverage$26.67 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $25,844 1 95.9%
Grant $630.00 1 2.3%
Travel and Lodging $400.00 1 1.5%
Education $43.74 3 0.2%
Food and Beverage $26.67 1 0.1%

Payments by Type

Research
$25,844
1 transactions
General
$1,100
6 transactions

Top Paying Companies

Company Total Records Latest Year
Eli Lilly and Company $25,844 1 $0 (2022)
Lilly USA, LLC $1,030 2 $0 (2018)
AbbVie Inc. $43.74 3 $0 (2020)
Abbott Laboratories $26.67 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $25,871 2 Eli Lilly and Company ($25,844)
2020 $14.58 1 AbbVie Inc. ($14.58)
2019 $29.16 2 AbbVie, Inc. ($29.16)
2018 $400.00 1 Lilly USA, LLC ($400.00)
2017 $630.00 1 Lilly USA, LLC ($630.00)

All Payment Transactions

7 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/08/2022 Eli Lilly and Company Cash or cash equivalent $25,844.00 Research
Study: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH AN OPEN-LABEL EXTENSION ASSESSING THE EFFICACY, SAFETY, AND PHARMACOKINETICS PHARMACODYNAMICS OF TIRZEPATIDE IN PEDIATRIC AND ADOLESCENT PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN, OR BASAL INSULIN, OR BOTH
06/01/2022 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $26.67 General
Category: Neuromodulation
01/09/2020 AbbVie Inc. LUPRON DEPOT (Drug) Education In-kind items and services $14.58 General
Category: ENDOCRINOLOGY
06/25/2019 AbbVie, Inc. Lupron Depot (Drug) Education In-kind items and services $14.58 General
Category: Endocrinology
03/27/2019 AbbVie, Inc. Lupron Depot (Drug) Education In-kind items and services $14.58 General
Category: Endocrinology
04/18/2018 Lilly USA, LLC Travel and Lodging In-kind items and services $400.00 General
07/18/2017 Lilly USA, LLC Grant Cash or cash equivalent $630.00 General

Research Studies & Clinical Trials

Study Name Company Amount Records
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH AN OPEN-LABEL EXTENSION ASSESSING THE EFFICACY, SAFETY, AND PHARMACOKINETICS PHARMACODYNAMICS OF TIRZEPATIDE IN PEDIATRIC AND ADOLESCENT PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN, OR BASAL INSULIN, OR BOTH Eli Lilly and Company $25,844 1

About Dr. David Hansen, MD

Dr. David Hansen, MD is a Pediatrics healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1003105768.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hansen, MD has received a total of $26,944 in payments from pharmaceutical and medical device companies, with $25,871 received in 2022. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "" ($25,844).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Endocrinology, Pediatric Endocrinology
  • Location Syracuse, NY
  • Active Since 04/04/2011
  • Last Updated 06/23/2023
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1003105768

Products in Payments

  • Lupron Depot (Drug) $29.16
  • PROCLAIM (Device) $26.67
  • LUPRON DEPOT (Drug) $14.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Syracuse